简介:
Overview
This protocol describes methods for delivering epigenomic editors into human cells using CRISPR-based techniques. By fusing chromatin effectors to dCas9, targeted gene modulation can be achieved without introducing toxic DNA breaks.
Key Study Components
Area of Science
- Neuroscience
- Genetics
- Cell Biology
Background
- Efficient delivery of epigenome editors into cells is a significant challenge.
- Maintaining precise target specificity is crucial for successful gene modulation.
- Stable or transient gene repression can be difficult to achieve.
- This protocol avoids cleaving mechanisms to reduce toxicity and genomic instability.
Purpose of Study
- To design and deliver epigenomic editors into human cells.
- To enable targeted gene modulation without toxic DNA breaks.
- To provide methods for controlled gene expression modulation.
Methods Used
- Plasmid DNA transfection
- mRNA nucleofection
- Fusion of chromatin effectors to dCas9
- Avoidance of cleaving mechanisms
Main Results
- Successful delivery of epigenome editors into human cells.
- Targeted gene modulation achieved without introducing DNA breaks.
- Reduction in toxicity and genomic instability observed.
- Methods allow for controlled gene expression modulation.
Conclusions
- This protocol provides effective methods for epigenome editing.
- It addresses key challenges in gene modulation techniques.
- Future applications may enhance gene therapy approaches.
What is CRISPR-based epigenome editing?
CRISPR-based epigenome editing involves modifying gene expression without altering the DNA sequence, using tools like dCas9.
What are the delivery methods described in the protocol?
The protocol describes plasmid DNA transfection and mRNA nucleofection as delivery methods for epigenomic editors.
Why is avoiding DNA breaks important?
Avoiding DNA breaks reduces toxicity and genomic instability, making the editing process safer for cells.
What challenges does this research address?
It addresses challenges in delivering epigenome editors efficiently and ensuring target specificity.
What are chromatin effectors?
Chromatin effectors are proteins that can modify chromatin structure to regulate gene expression.
Can this method be used for gene therapy?
Yes, the methods described may enhance gene therapy approaches by allowing targeted modulation of gene expression.